Logo image of MAV

PIONEER MUNICIPAL HIGH INC (MAV) Stock Price, Quote, News and Overview

NYSE:MAV - New York Stock Exchange, Inc. - US7237621005 - Currency: USD

7.86  0 (0%)

Fundamental Rating

2

Taking everything into account, MAV scores 2 out of 10 in our fundamental rating. MAV was compared to 0 industry peers in the Unkown industry. The financial health of MAV is average, but there are quite some concerns on its profitability. MAV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MAV had negative earnings in the past year.
In the past year MAV had a positive cash flow from operations.
In multiple years MAV reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: MAV reported negative operating cash flow in multiple years.
MAV Yearly Net Income VS EBIT VS OCF VS FCFMAV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

The last Return On Invested Capital (2.12%) for MAV is above the 3 year average (2.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -5.66%
ROE -9.22%
ROIC 2.12%
ROA(3y)-1.9%
ROA(5y)0.22%
ROE(3y)-3.23%
ROE(5y)-0.24%
ROIC(3y)2.11%
ROIC(5y)2.31%
MAV Yearly ROA, ROE, ROICMAV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

In the last couple of years the Operating Margin of MAV has declined.
In the last couple of years the Gross Margin of MAV has declined.
Industry RankSector Rank
OM 55.81%
PM (TTM) N/A
GM 57.69%
OM growth 3Y-3.11%
OM growth 5Y-7.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.71%
GM growth 5Y-7.57%
MAV Yearly Profit, Operating, Gross MarginsMAV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

6

2. Health

2.1 Basic Checks

The number of shares outstanding for MAV remains at a similar level compared to 1 year ago.
MAV has about the same amout of shares outstanding than it did 5 years ago.
There is no outstanding debt for MAV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MAV Yearly Shares OutstandingMAV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
MAV Yearly Total Debt VS Total AssetsMAV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.72, we must say that MAV is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for MAV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.72
ROIC/WACCN/A
WACCN/A
MAV Yearly LT Debt VS Equity VS FCFMAV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

MAV has a Current Ratio of 6.30. This indicates that MAV is financially healthy and has no problem in meeting its short term obligations.
MAV has a Quick Ratio of 6.30. This indicates that MAV is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 6.3
Quick Ratio 6.3
MAV Yearly Current Assets VS Current LiabilitesMAV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

0

3. Growth

3.1 Past

MAV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.25%.
MAV shows a small growth in Revenue. In the last year, the Revenue has grown by 3.05%.
MAV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.29% yearly.
EPS 1Y (TTM)2.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%190.27%
Revenue 1Y (TTM)3.05%
Revenue growth 3Y-3.02%
Revenue growth 5Y-3.29%
Sales Q2Q%7.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MAV Yearly Revenue VS EstimatesMAV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAV Price Earnings VS Forward Price EarningsMAV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 3.6
EV/EBITDA N/A
MAV Per share dataMAV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

MAV has a Yearly Dividend Yield of 4.55%, which is a nice return.
MAV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 4.55%

5.2 History

MAV has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MAV Yearly Dividends per shareMAV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MAV are negative and hence is the payout ratio. MAV will probably not be able to sustain this dividend level.
DP-57.56%
EPS Next 2YN/A
EPS Next 3YN/A
MAV Yearly Income VS Free CF VS DividendMAV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

PIONEER MUNICIPAL HIGH INC

NYSE:MAV (4/21/2025, 2:18:57 PM)

7.86

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners55.74%
Inst Owner Change0.04%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap187.93M
Analysts0
Price TargetN/A
Short Float %0.14%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield 4.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-57.56%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-17 2025-04-17 (0.0325)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.7
P/FCF 3.6
P/OCF 3.6
P/B 0.84
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)-0.87
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.18
FCFY27.78%
OCF(TTM)2.18
OCFY27.78%
SpS0.73
BVpS9.39
TBVpS9.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.66%
ROE -9.22%
ROCE 2.69%
ROIC 2.12%
ROICexc 2.13%
ROICexgc 2.13%
OM 55.81%
PM (TTM) N/A
GM 57.69%
FCFM 297.32%
ROA(3y)-1.9%
ROA(5y)0.22%
ROE(3y)-3.23%
ROE(5y)-0.24%
ROIC(3y)2.11%
ROIC(5y)2.31%
ROICexc(3y)2.11%
ROICexc(5y)2.32%
ROICexgc(3y)2.11%
ROICexgc(5y)2.32%
ROCE(3y)2.67%
ROCE(5y)2.92%
ROICexcg growth 3Y-0.78%
ROICexcg growth 5Y-7.66%
ROICexc growth 3Y-0.76%
ROICexc growth 5Y-7.65%
OM growth 3Y-3.11%
OM growth 5Y-7.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.71%
GM growth 5Y-7.57%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.05
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.3
Quick Ratio 6.3
Altman-Z 0.72
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%190.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.05%
Revenue growth 3Y-3.02%
Revenue growth 5Y-3.29%
Sales Q2Q%7.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.81%
EBIT growth 3Y-6.03%
EBIT growth 5Y-10.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y360.41%
FCF growth 3Y28.39%
FCF growth 5YN/A
OCF growth 1Y360.41%
OCF growth 3Y28.39%
OCF growth 5YN/A